Indicated for combination antiretroviral treatment of HIV-1-infected patients, co-administered with 200 mg of ritonavir, who are treatment-experienced and infected with HIV-1 strains resistant to more than one protease inhibitor.
Product Key Facts
Sincerely Pharmaceutical Tech
Client Success Team (CRM),
Please fill the all required fields....!!
Sincerely Packaging Labelling